Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis
about
Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors.Methotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheumatoid arthritis.Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis.Screening for key genes and transcription factors in ankylosing spondylitis by RNA-Seq.
P2860
Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Effect of Tumor Necrosis Facto ...... sors in Ankylosing Spondylitis
@ast
Effect of Tumor Necrosis Facto ...... sors in Ankylosing Spondylitis
@en
type
label
Effect of Tumor Necrosis Facto ...... sors in Ankylosing Spondylitis
@ast
Effect of Tumor Necrosis Facto ...... sors in Ankylosing Spondylitis
@en
prefLabel
Effect of Tumor Necrosis Facto ...... sors in Ankylosing Spondylitis
@ast
Effect of Tumor Necrosis Facto ...... sors in Ankylosing Spondylitis
@en
P2093
P2860
P50
P1433
P1476
Effect of Tumor Necrosis Facto ...... sors in Ankylosing Spondylitis
@en
P2093
Elsa Vieira-Sousa
João E Fonseca
Raquel Campanilho-Marques
Rita Raposeiro
P2860
P304
P356
10.1371/JOURNAL.PONE.0144655
P407
P577
2015-12-16T00:00:00Z